0001641226-23-000001.txt : 20231222 0001641226-23-000001.hdr.sgml : 20231222 20231222112212 ACCESSION NUMBER: 0001641226-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20231222 DATE AS OF CHANGE: 20231222 EFFECTIVENESS DATE: 20231222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OcuTerra Therapeutics, Inc. CENTRAL INDEX KEY: 0001641226 ORGANIZATION NAME: IRS NUMBER: 274249384 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-500574 FILM NUMBER: 231508063 BUSINESS ADDRESS: STREET 1: 85 E. INDIA ROW STREET 2: SUITE 21G CITY: BOSTON STATE: MA ZIP: 02110 BUSINESS PHONE: 339-234-1333 MAIL ADDRESS: STREET 1: 85 E. INDIA ROW STREET 2: SUITE 21G CITY: BOSTON STATE: MA ZIP: 02110 FORMER COMPANY: FORMER CONFORMED NAME: SciFluor Life Sciences, Inc. DATE OF NAME CHANGE: 20150504 D 1 primary_doc.xml X0708 D LIVE 0001641226 OcuTerra Therapeutics, Inc. 50 MILK STREET 16th FLOOR BOSTON MA MASSACHUSETTS 02109 617-701-7382 DELAWARE SciFluor Life Sciences, Inc. Corporation true Kerrie Brady 50 Milk Street 16th Floor Boston MA MASSACHUSETTS 02109 Executive Officer Director David J. Tanzer 50 Milk Street 16th Floor Boston MA MASSACHUSETTS 02109 Executive Officer D. Scott Edwards 50 Milk Street 16th Floor Boston MA MASSACHUSETTS 02109 Executive Officer William Steinkrauss 50 Milk Street 16th Floor Boston MA MASSACHUSETTS 02109 Executive Officer Brenton Saunders 50 Milk Street 16th Floor Boston MA MASSACHUSETTS 02109 Director William H. Koster 50 Milk Street 16th Floor Boston MA MASSACHUSETTS 02109 Director Barbara Ryan 50 Milk Street 16th Floor Boston MA MASSACHUSETTS 02109 Director Robert Ruffolo 50 Milk Street 16th Floor Boston MA MASSACHUSETTS 02109 Director Robin Steele 50 Milk Street 16th Floor Boston MA MASSACHUSETTS 02109 Director Bruce Failing 50 Milk Street 16th Floor Boston MA MASSACHUSETTS 02109 Director Other Decline to Disclose 06b false 2023-12-14 false true true true true false 0 Maxim Group LLC 120708 None None 300 Park Avenue 16th Floor New York NY NEW YORK 10122 All States false 30000000 6658827 23341173 false 84 665882 true 0 0 true A portion of the proceeds of this transaction may be used to pay the salaries of the Issuer's executive employees listed on Item 3 in the ordinary course of business. false OcuTerra Therapeutics, Inc. /s/ Kerrie Brady Kerrie Brady Chief Executive Officer 2023-12-22